Vertex Pharmaceuticals Incorporated (VRTX) Stock Price Today
Key Stats
- $122.68BMarket Cap
- -Volume
- HealthSector
- $529.5952W High
- $366.5452W Low
- -Typical Hold Time
- $116.81BEnterprise Value
- -Div Yield
- -Trading Activity
Track Vertex Pharmaceuticals Incorporated (VRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $366.54 and a high of $529.59, highlighting its annual price range. Buy and sell Vertex Pharmaceuticals Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Most Recent News
Man Group PLC discloses 0.57% stake in Bodycote Plc, reducing long equity swap positions.
Man Group PLC has publicly disclosed holding a 0.57% interest in Bodycote Plc as of August 6, 2026. The disclosure reveals that Man Group is reducing its long positions through multiple equity swap transactions at varying prices. This update is part ...

Global influenza vaccine market to grow to $13.32B by 2030, driven by aging population and vaccine innovations
The global influenza vaccine market, valued at $8.96 billion in 2024, is projected to reach $13.32 billion by 2030 with a 7% annual growth rate. Growth is fueled by rising public health awareness, an expanding elderly population, government immunizat...

Investec Bank discloses share dealings for Gooch & Housego on August 6, 2026.
Investec Bank plc, acting as advisor and broker for Gooch & Housego plc, disclosed its trading activity on August 6, 2026. The bank purchased 3,348 ordinary shares at a price of 1225 pence each and sold 5,166 shares between 1225 and 1230 pence. There...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.